Bills · S 4066
IN COMMITTEE· 119TH CONGRESS
Senate BillS 4066Health
Safeguarding Women from Chemical Abortion Act
INTRO MAR 11· LAST ACTION MAR 11
READING
4MIN
COSPONSORS
7
READER REACTIONS0 TOTAL
NO VOTES YET · BE THE FIRST
- Introduced only
LEGISLATIVE PROGRESS
STEP 2 / 8Introduced
In Committee
Reported
Passed Senate
Passed House
Conference
To President
Became Law
WHAT THE BILL DOES
AI-writtenThis bill matters because if it becomes law, it would effectively ban medication abortion using mifepristone across the entire country. Mifepristone is one of two drugs typically used in a medication abortion and has been federally approved for over two decades. Ending its approval would remove a widely used and accessible method of abortion.
Voters should care because this bill would significantly change the landscape of abortion access, potentially pushing more individuals towards surgical procedures or making it harder to access abortion care at all. It also bypasses the standard Food and Drug Administration (FDA) process for drug approval and withdrawal, setting a precedent for Congress to directly intervene in drug regulation, which could have broader implications for other medications.
KEY PROVISIONS
4AI-extractedPROVISION 01
The bill would withdraw the federal approval for mifepristone when used to end an intrauterine pregnancy.
This would remove a key drug for medication abortion from the market, effectively making it federally illegal for this purpose.
PROVISION 02
Introducing or delivering mifepristone for abortion across state lines would be considered a violation of the Federal Food, Drug, and Cosmetic Act.
This provision would make it illegal to distribute or sell mifepristone for abortion in interstate commerce.
PROVISION 03
The bill would consider mifepristone 'misbranded' if its labeling indicates it can be used for terminating an intrauterine pregnancy.
This would prevent manufacturers from labeling mifepristone for abortion, further restricting its availability and use for that purpose.
PROVISION 04
It would establish a federal pathway for individuals to sue manufacturers of mifepristone if they suffer physical or mental harm attributed to the drug.
This creates a new legal avenue for individuals to seek compensation from drug companies for perceived harm related to medication abortion.
SPONSORSHIP
1 + 7
R· Missouri
YRS IN OFFICE
7
BILLS LED
51
COSPONSOR BREAKDOWNBIPARTISAN · 0%
DEM 0 REP 7 IND 0
ACTION TIMELINE
2 EVENTSMAR 11
Introduced in Senate
MAR 11
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
BILL INFO
TypeSenate Bill
NumberS 4066
Congress119th
StatusIn Committee
IntroducedMar 11, 2026
Last actionMar 11, 2026
READER REACTIONS
OVERALL SENTIMENT
No reactions yet. Be the first to weigh in.
Discussion
Loading comments...
IN COMMITTEE· 119TH CONGRESS · HEALTH, EDUCATION, LABOR, AND PENSIONS COMMITTEE · INTRODUCED MAR 11, 2026
Senate BillS 4066Health
Safeguarding Women from Chemical Abortion Act
INTRODUCED MAR 11, 2026· LAST ACTION MAR 11, 2026
PASSAGE CHANCES
—%
READING
4 min
COSPONSORS
7
COMPLEXITY
Moderate
